Cancer Generic Drugs
- All
- News
- Videos
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine
Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka.
-
Dr Reddy's Forays Into Colombian Market, To Sell Cancer Drugs
Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
AstraZeneca Q2 Earnings Hit By Waning Cholesterol Drug Sales
Generic competition to cholesterol buster Crestor in the US market pushed second quarter earnings down by nearly a third at drug maker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes.
-
Natco Settles Patent Litigation With Celgene on Cancer Drug
Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic Lenalidomide capsules used for treatment of multiple myeloma.
-
Sun Pharma Gets US Regulator's Nod for Cancer Treatment Drug
Drug major Sun Pharmaceutical Industries on Friday said one of its subsidiaries has received approval of the US Food and Drug Administration (FDA) to manufacture and market generic version of Novartis' Gleevec, used in treatment of cancer, in America.
-
Germany's Stada Agrees Oncology Deal With Hetero Drugs
German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
-
Bayer Fails to Block Generic Cancer Drug in Supreme Court
German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday.
-
Delhi High Court bars export of Natco's generic cancer treatment drug
The Delhi High Court has barred export of generic kidney and liver cancer medication Sorefenat manufactured by Natco Pharma Ltd on a plea of German drug major Bayer Corporation.
-
Biocon to start selling breast cancer treatment drug in India in February
Biocon Ltd said its generic version of Roche's Herceptin breast cancer treatment drug would be available to patients in India from the first week of February.
-
Glenmark faces patent infringement suit for cancer drug in US
The complaint has been filed against Glenmark trying to commercialise the product before the expiry of patent which is a generic version of Treanda, it added.
-
Biocon, Mylan get DGCA nod for breast cancer drug
Biocon Ltd said on Tuesday it has won approval from the Drug Controller General of India (DGCA) for marketing a generic version of Roche's Herceptin, used in breast cancer treatment.
-
Dr Reddys launch generic cancer drug in US market
The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's abbreviated new drug applications (ANDA), it said in a statement.
-
India says its drugs safe despite Ranbaxy generics fraud
India, known as the "pharmacy to the world", today defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine
Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka.
-
Dr Reddy's Forays Into Colombian Market, To Sell Cancer Drugs
Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
AstraZeneca Q2 Earnings Hit By Waning Cholesterol Drug Sales
Generic competition to cholesterol buster Crestor in the US market pushed second quarter earnings down by nearly a third at drug maker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes.
-
Natco Settles Patent Litigation With Celgene on Cancer Drug
Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic Lenalidomide capsules used for treatment of multiple myeloma.
-
Sun Pharma Gets US Regulator's Nod for Cancer Treatment Drug
Drug major Sun Pharmaceutical Industries on Friday said one of its subsidiaries has received approval of the US Food and Drug Administration (FDA) to manufacture and market generic version of Novartis' Gleevec, used in treatment of cancer, in America.
-
Germany's Stada Agrees Oncology Deal With Hetero Drugs
German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
-
Bayer Fails to Block Generic Cancer Drug in Supreme Court
German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday.
-
Delhi High Court bars export of Natco's generic cancer treatment drug
The Delhi High Court has barred export of generic kidney and liver cancer medication Sorefenat manufactured by Natco Pharma Ltd on a plea of German drug major Bayer Corporation.
-
Biocon to start selling breast cancer treatment drug in India in February
Biocon Ltd said its generic version of Roche's Herceptin breast cancer treatment drug would be available to patients in India from the first week of February.
-
Glenmark faces patent infringement suit for cancer drug in US
The complaint has been filed against Glenmark trying to commercialise the product before the expiry of patent which is a generic version of Treanda, it added.
-
Biocon, Mylan get DGCA nod for breast cancer drug
Biocon Ltd said on Tuesday it has won approval from the Drug Controller General of India (DGCA) for marketing a generic version of Roche's Herceptin, used in breast cancer treatment.
-
Dr Reddys launch generic cancer drug in US market
The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's abbreviated new drug applications (ANDA), it said in a statement.
-
India says its drugs safe despite Ranbaxy generics fraud
India, known as the "pharmacy to the world", today defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.
